ALEXIS HESS: Open Payments
NPI 1750964011 · SAVANNAH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$308 in 12 payments from 11 companies in 2025. Trend: 2023 $1,797 · 2024 $483 · 2025 $308
Food & beverage: $308
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $45 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $35 |
| Vanda Pharmaceuticals Inc. | 1 | $34 |
| SANOFI-AVENTIS U.S. LLC | 1 | $33 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $32 |
| Galderma Laboratories, L.P. | 1 | $27 |
| Cleerly, Inc. | 1 | $24 |
| Aimmune Therapeutics, Inc. | 1 | $22 |
| Exact Sciences Corporation | 1 | $22 |
| PFIZER INC. | 1 | $20 |
Products named: FANAPT, TZIELD, CAPLYTA, REXULTI, Cleerly Ischemia, ZENPEP, Cologuard Collection Kit, COMIRNATY.
Industry payments across GA — which companies pay providers there.
